|
Sponsored by
The Pharmaceutical
Compliance Forum
|
NINTH ANNUAL PHARMACEUTICAL REGULATORY AND COMPLIANCE CONGRESS AND BEST PRACTICES FORUM
Transformational Learning - Effective Knowledge Exchange
October 27 - 29, 2008
Hyatt Regency On Capitol Hill
Washington, DC
|
|
SPEAKER PRESENTATION PROPOSALS
|
Speaker/Presentation Proposals for the Ninth Pharma Congress May Be Submitted Through Our Online Form
- Click Here -
|
|
2007 PHARMA CONGRESS MULTIMEDIA
|
Watch video of the 2007 Pharma Congress on the go. The Pharma Congress offers Podcasting of all general sessions on a 30gb Video iPOD™, a CD-ROM, or a Flash Drive. Concurrent breakout session audio and all related presentation materials are also included on each multimedia format.
Click here to order! |
|
|
|
2007 KEYNOTE SPEAKERS
|
Robert A. Ingram
Vice Chairman Pharmaceuticals, GlaxoSmithKline, Chairman, OSI Pharmaceuticals, Inc., Chairman, VALEANT Pharmaceuticals International, Research Triangle Park, NC
|
|
Mark W. Kline, MD
Professor of Pediatrics, Chief, Retrovirology Clinic, Texas Children's Hospital, Director, Baylor International Pediatric AIDS Initiative, Assistant Program Director, General Clinical Research Center, Baylor College of Medicine, Houston, TX
|
|
|
|
Peter Lurie, MD, MPH
Deputy Director, Public Citizen's Health Research Group, Washington, DC
|
|
David A. Shore, PhD
Associate Dean, Founding Director, Trust Initiative, Harvard School of Public Health, Author, The Trust Prescription for Healthcare: Building Your Reputation with Consumers, Boston, MA
|
|
Malcolm Sparrow, MPA, PhD
Professor of Practice of Public Management, Kennedy School of Government, Harvard University, Author, The Regulatory Craft: Controlling Risks, Solving Problems, and Managing Compliance, Cambridge, MA
|
|
|
|
|
|
2007 GOVERNMENT KEYNOTE SPEAKERS
|
Kristina Borror, PhD
Director, Division of Compliance Oversight, Office for Human Research Protections, Department of Health and Human Services, Rockville, MD
|
|
Jim Donahue, Esq.
Pennsylvania Chief Deputy Attorney General, Antitrust, Pennsylvania Office of the Attorney General, Harrisburg, PA
|
|
Joyce M. Greenleaf, MBA
Regional Inspector General for Evaluation and Inspections, Office of Inspector General, Department of Health and Human Services, Boston, MA
|
|
John Guthrie, Esq.
Director, Medicaid Fraud Control Unit, Office of Ohio Attorney General, Columbus, OH
|
|
David Hart, Esq.
Assistant Attorney General, Consumer Protection, Oregon Office of the Attorney General, Salem, OR
|
|
William Jacobson, Esq.
Assistant Chief, Fraud Section, Criminal Division, United States Department of Justice, Washington, DC
|
|
|
|
John Krayniak, Esq.
Assistant Attorney General, Chief, Medicaid Fraud Section, New Jersey Office of the Attorney General, Trenton, NJ
|
|
Lewis Morris, Esq.
Chief Counsel, Office of Inspector General, Department of Health and Human Services, Washington, DC
|
|
Jeffrey M. Senger, Esq.
Acting Chief Counsel, Food and Drug Administration, Washington, DC
|
|
James G. Sheehan, Esq.
New York State Medicaid Inspector General, Former Associate United States Attorney, US Attorney's Office, Eastern District of Pennsylvania, Albany, NY
|
|
Susan Winkler, Esq.
Assistant United States Attorney, Deputy Health Care Fraud Chief, United States Attorney's Office, District of Massachusetts, Boston, MA
|
|
Susan J. Miller
Managing Attorney, Antitrust & Civil Medicaid Fraud Division, Texas Office of the Attorney General, Austin, TX
|
|
|
|
|
2007 LEADING QUI TAM ATTORNEYS
|
Peter Chatfield, Esq.
Partner, Phillips & Cohen LLP, Washington, DC
|
|
Mark Allen Kleiman, Esq.
Partner, Law Offices of Mark Allen Kleiman, Los Angeles, CA |
|
|
|
Stephen Meagher, Esq.
Partner, Law Offices of Stephen Meagher, San Francisco, CA
|
|
Lesley Ann Skillen, Esq.
Partner, Getnick & Getnick, New York, NY |
|
|
Dara A. Corrigan, Esq.
Partner, Arnold & Porter, Former Acting Inspector General, Department of Health and Human Services, Washington, DC (Moderator of Qui Tam Panel)
|
|
|
|
|
|
2007 CONGRESS CO CHAIRS
|
Sujata T. Dayal, Esq.
Counsel, Domestic Legal Operations, Abbott Laboratories, Abbott Park, IL
|
|
Lori Queisser
Senior Vice President, Global Compliance and Business Practices, Schering-Plough Corporation, Kenilworth, NJ
|
|
|
|
Arjun Rajaratnam, Esq.
Vice President & Compliance Officer - US Pharmaceuticals, GlaxoSmithKline, Research Triangle Park, NC
|
|
Bert Weinstein, Esq.
Vice President, Corporate Compliance, Purdue Pharma LP, Stamford, CT
|
|
|
|
|
SAVE THE DATE
|
INTERNATIONAL MEDICAL DEVICE COMPLIANCE CONGRESS
Sponsored by Pharmaceutical Compliance Forum
May 26 - 27, 2008
Paris, France
www.InternationalDeviceCongress.com
|
FOURTH FDA REGULATORY AND COMPLIANCE SYMPOSIUM AT HARVARD
Sponsored by FDAnews, Harvard Health Policy Review and Health Affairs
August 2008
Harvard University
Cambridge, MA
www.FDASymposium.com
|
|
|
SECOND INTERNATIONAL PHARMACEUTICAL REGULATORY AND COMPLIANCE CONGRESS
Sponsored by Pharmaceutical Compliance Forum
May 28 - 29, 2008
Paris, France
www.InternationalPharmaCongress.com
|
NINTH ANNUAL PHARMACEUTICAL REGULATORY AND COMPLIANCE CONGRESS
Sponsored by Pharmaceutical Compliance Forum
October 27 - 29, 2008
Washington, DC
www.PharmaCongress.com
|
|
|
|
|
PCF PHARMA CONGRESS PLANNING COMMITTEE
|
Sujata T. Dayal, Esq.
Ethics and Compliance Officer - PPG, Abbott Laboratories (Co chair)
Lori Queisser
Senior Vice President, Global Compliance and Business Practices, Schering-Plough Corporation, Kenilworth, NJ (Co chair)
Arjun Rajaratnam
Vice President & Compliance Officer - US Pharmaceuticals, GlaxoSmithKline (Co chair)
Bert Weinstein, Esq.
Vice President, Corporate Compliance, Purdue Pharma LP (Co chair)
Ted Acosta, Esq.
Principal, Ernst & Young LLP
Scott Bass, Esq.
Partner, Sidley Austin LLP
John T. Bentivoglio, Esq.
Partner, King & Spalding LLP
Kathleen M. Boozang, Esq.
Associate Dean and Professor of Law, Cofounder, Health Law & Policy Program, and Health Law, Science and Technology Graduate Programs, Seton Hall University School of Law
Robert P. Brady, Esq.
Partner, Hogan & Hartson
David B. Chandler, Ph.D., DABT
Director of Outcomes and Analysis Corporate Compliance, Amgen
Colleen Craven
Vice President, Ethics and Corporate Compliance, Endo Pharmaceuticals
|
|
David Davidovic
Senior Director, Business Practices, Genentech
William T. Fitzgerald
Vice President, Global Compliance, Alcon Laboratories
Wendy C. Goldstein, Esq.
Partner, Epstein Becker & Green
Peter N. Grant, JD, Ph.D.
President, Health Care Conference Administrators, LLC
Stephen Kanovsky
US Corporate Compliance Officer, Sanofi-Aventis US, Inc.
Keith M. Korenchuk, JD, MPH
Covington & Burling LLP
Daniel A. Kracov, Esq.
Partner, Arnold & Porter
Steve Mohr, Esq.
Global Compliance Officer, AstraZeneca
Brian Riewerts
Partner, Global Pharmaceutical Advisory Services Group, PricewaterhouseCoopers LLP
Sue Seferian, Esq.
Senior Counsel, Johnson & Johnson
Paul J. Silver
Managing Director, Huron Consulting Group
Jonathan K. Sprole
Chief Compliance Officer, Bristol-Myers Squibb Company
Jack T. Tanselle
Director, Navigant Consulting, Inc.
Caroline West, Esq.
Senior Vice President, Chief Compliance and Risk Officer, Shire Pharmaceuticals, Inc.
|
|
|
|
|
|
|
SPONSORED BY:
|
|
|
GRANTORS:
|
|
DIAMOND
|
|
|
SILVER
|
|
|
BRONZE
|
|
|
OTHER SPONSORS:
|
|
ASSOCIATIONS
|
|
|
PUBLICATIONS
|
|
|
|
|
|
